Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

ALMA - Pioneering Smart Lens to Revolutionize Eye Care

Ziel

Nearly 5M people in the EU, the UK, and the US are affected by irregular corneas, a condition characterized by imperfections on the corneal surface. Irregular corneas disrupt the smooth, regular structure needed to focus light evenly onto the retina, leading to distorted or blurry vision. This condition can result from various causes, including diseases, injuries, or previous surgeries. Patients with irregular corneas often experience significant visual disturbances and may struggle with glare, halos, and night vision issues.
Treatment options range from spectacles and various contact lenses to more invasive procedures like corneal transplants. The current state-of-the-art solutions, including rigid scleral lenses, often fail to fully address higher order aberrations, leaving patients with persistent vision problems.
After 10+ years of research and breakthroughs in smart contact lens design, construction, and operation, Azalea has developed ALMA, the first patented autonomous and adaptable Smart Lens for patients with irregular corneas. This revolutionary solution integrates advanced light management technology into a scleral lens platform, featuring a dynamic light filter, a custom microchip, and a wireless smart case for charging and disinfection. ALMA provides improved visual quality, enhanced comfort, and real-time adaptation to environmental conditions, offering a new standard of care for patients with irregular corneas.
With EIC’s support, Azalea plans to conduct First-in-Human and pivotal clinical trials to obtain CE mark and FDA approvals for the commercialization of the ALMA Smart Lens. Our initial focus is on the irregular cornea market across Europe, the UK, and the US. This market encompasses a total addressable population of 614k patients with irregular corneas, representing a market opportunity of €3B. The project is expected to significantly impact Azalea, projecting €130M in revenues and reaching 135 employees within 5 years of commercialization.

Wissenschaftliches Gebiet (EuroSciVoc)

Dieses Projekt wurde noch nicht bei EuroSciVoc klassifiziert.
Schlagen Sie die Wissenschaftsbereiche vor, die Ihrer Einschätzung nach besonders relevant sind, und helfen Sie uns, unseren Klassifizierungsdienst zu verbessern.

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-EIC-ACC - HORIZON EIC Accelerator

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-EIC-2026-ACCELERATOR-02

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

AZALEA VISION
Netto-EU-Beitrag
€ 2 498 825,00
Adresse
TECHNOLOGIEPARK-ZWIJNAARDE 122
9052 GAND
Belgien
KMU
Ja
Region
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
Keine Daten